Great strides have been made in the advancement of interventional stroke management over the past few years. Prior studies have looked at patient selection and assessment to determine whether medical management or endovascular treatment (EVT) is warranted. For those patients triaged into the EVT pathway, additional factors must be con-sidered, as patient anatomy, thrombus composition, and thrombus lo-cation vary. Prior administration of the thrombolytic agent intravenous tissue plasminogen activator (IV-tPA) should not influence the decision to perform mechanical thrombectomy.
|Original language||English (US)|
|Number of pages||7|
|State||Published - Nov 1 2021|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging